1887

Chapter 16.6 : Brucellosis— spp.

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Brucellosis— spp., Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap16.6-1.gif /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap16.6-2.gif

Abstract:

is a fastidious, aerobic, small, Gram-negative coccobacillus that is neither motile nor spore-forming ( ). is considered an “Overlap select agent” because it not only has the potential to pose a threat to public health and safety, but it also poses a threat to animal health and animal products.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 16.6–1
Figure 16.6–1

Gram stain.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 16.6–2
Figure 16.6–2

BAP.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 16.6–3
Figure 16.6–3

urea.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 16.6–4
Figure 16.6–4

urea disk.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 16.6–5
Figure 16.6–5

identification flowchart.

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818814.chap16.6
1. Mantur BG, Amarnath SK, Shinde RS. 2007. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25:188202.
2. Weyant RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, Daneshvar MI. 1995. Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, 2nd ed. Williams & Wilkins, Baltimore, MD.
3. Centers for Disease Control and Prevention. 2012. Summary of notifiable diseases – United States, 2010. MMWR Morb Mortal Wkly Rep 59:1111.
4. Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. 2000. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 38:20052006.
5. Sewell DL. 1995. Laboratory-associated infections and biosafety. Clin Microbiol Rev 8:389405.
6. Staszkiewicz J, Lewis CM, Colvile J, Zervos M, Band J. 1991. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol 29:287290.
7. Mesner O, Riesenberg K, Biliar N, Borstein E, Bouhnik L, Peled N, Yagupsky P. 2007. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 45:e135e140.
8. Osterman B, Moriyon I. 2006. Report of the International Committee on Systematics Prokaryotes, Subcommittee on the taxonomy of Brucella. Int J Syst Evol Microbiol 56:11731175.
9. De BK, Stauffer L, Koylass MS, Sharp SE, Gee JE, Heisel LO, Steigerwalt AG, Vega R, Clark TA, Daneshvar MI, Wilkins PP, Whatmore AM. 2008. Novel Brucella strain (BO1) associated with a prosthetic breast implant infection. J Clin Microbiol 46:4349.
10. Centers for Disease Control and Prevention. 2008. Public health consequences of a false-positive laboratory test result for Brucella – Florida, Georgia, and Michigan, 2005. MMWR Morb Mortal Wkly Rep 57:603605
11. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Institutes of Health. 2007. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th ed. U.S. Government Printing Office, Washington, DC. Available at http://www.cdc.gov/OD/OHS/biosfty/bmbl5/bmbl_5th_edition.
12. Bannatyne RM, Jackson MC, Memish Z. 1997. Rapid detection of Brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 35:26732674.
13. Yagupsky P. 1999. Detection of brucellae in blood cultures. J Clin Microbiol 37:34373442.
14. Yagupsky P, Peled N, Prss J, Abramson O, Abu-Rashid M. 1997. Comparison of BACTEC 9240 Peds Plus medium and Isolator 1.5 microbial tube for the detection of Brucella melitensis from blood cultures. J Clin Microbiol 35:13821385.
15. Castaneda MR. 1947. A practical method for routine blood cultures in brucellosis. Proc Soc Exp Biol Med 64:114.
16. Espinosa BJ, Chacaltana J, Mulder M, , et alet al. 2009. Comparison of culture techniques at different stages of brucellosis. Am J Trop Med Hyg 80:625627.
17. Ederer GM, Chu JH, Blazevic DJ. 1971. Rapid test for urease and phenylalanine deaminase production. Appl Microbiol 21: 545.
18.CLSI. 2010. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, 2nd ed. Approved standard M45A2. CLSI, Wayne, PA
19. Maves RC, Castillo R, Guillen A. 2011. Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Antimicrob Agents Chemother 55:12791281.
20. Solera J, Beato JL, Martinez-Alfaro E, Segura JC, de Tomas E. 2001. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. Clin Infect Dis 32:506509
21. Gomez M, Nieto J, Rosa C, Geijo P, Escribano M, Munoz A, Lopez C. 2008. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 15:10311033.

Tables

Generic image for table
Table 16.6–1

Collection and transport of clinical specimens for laboratory rule-out testing

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6
Generic image for table
Table 16.6–2

Differentiation of Brucella from other urea-positive, oxidase-positive, Gram-negative coccobacilli

Citation: Leber A. 2016. Brucellosis— spp., p 16.6.1-16.6.12. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch16.6

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error